Giorgio Silvestrelli Selected Research

Giorgio Silvestrelli Research Topics

Disease

25	Stroke (Strokes) 01/2022 - 04/2006
16	Ischemic Stroke 01/2022 - 01/2007
9	Atrial Fibrillation 01/2022 - 10/2010
7	Hemorrhage 01/2022 - 01/2007
5	Cerebral Hemorrhage 01/2021 - 01/2007
4	Hematoma 01/2020 - 08/2008
3	Hypertension (High Blood Pressure) 10/2021 - 04/2006
3	Brain Ischemia (Cerebral Ischemia) 01/2016 - 11/2008
3	Cognitive Dysfunction 08/2009 - 02/2006
2	Myocardial Infarction 03/2015 - 04/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2012 - 10/2010
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2009 - 11/2008
2	Dementia (Dementias) 11/2008 - 02/2006
2	Alzheimer Disease (Alzheimer's Disease) 02/2006 - 02/2006
1	Blood Vessel Dissection 01/2022
1	Infections 10/2021
1	COVID-19 10/2021
1	Pulmonary Embolism 01/2020
1	Venous Thromboembolism 01/2020
1	Leukoaraiosis 01/2019
1	Embolic Stroke 01/2019
1	Patent Foramen Ovale 01/2016
1	Embolism (Embolus) 01/2016
1	Migraine with Aura (Familial Hemiplegic Migraine) 04/2014
1	Obesity 06/2013
1	Lacunar Stroke 06/2012
1	Heart Failure 01/2012
1	Diabetes Mellitus 01/2012
1	Atherosclerosis 10/2010
1	Transient Ischemic Attack 10/2010
1	Cluster Headache (Cluster Headaches) 11/2008
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2008
1	Migraine Disorders (Migraine) 11/2008
1	Spasm (Spasms) 11/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2008
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 11/2008
1	Vascular Diseases (Vascular Disease) 01/2007

Drug/Important Bio-Agent (IBA)

12	AnticoagulantsIBA 01/2022 - 01/2007
4	Vitamin K FDA Link 01/2021 - 11/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2007
3	Antihypertensive Agents (Antihypertensives)IBA 04/2014 - 04/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2012 - 01/2007
3	Blood Glucose (Blood Sugar)IBA 01/2012 - 08/2008
3	Pharmaceutical PreparationsIBA 08/2009 - 04/2006
2	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 10/2010
2	CholesterolIBA 01/2016 - 01/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 02/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	ORALIT (ORS)IBA 10/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Dabigatran FDA Link 11/2017
1	apixabanIBA 11/2017
1	RivaroxabanIBA 11/2017
1	Factor V (Coagulation Factor V)IBA 03/2015
1	Prothrombin (Factor II)IBA 03/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2015
1	Antiphospholipid AntibodiesIBA 04/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	Biological ProductsIBA 06/2013
1	Particulate MatterIBA 06/2012
1	Environmental Pollutants (Pollutants, Environmental)IBA 06/2012
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2012
1	LDL CholesterolIBA 09/2009
1	Nicardipine (Dagan)FDA LinkGeneric 08/2009
1	1,4-dihydropyridine (dihydropyridine)IBA 11/2008
1	Nimodipine (Modus)FDA LinkGeneric 11/2008
1	Ramipril (Altace)FDA LinkGeneric 04/2006
1	Perindopril FDA LinkGeneric 04/2006
1	DiureticsIBA 04/2006
1	Atenolol (Tenormin)FDA LinkGeneric 04/2006
1	Indapamide FDA LinkGeneric 04/2006
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 04/2006
1	Losartan (Cozaar)FDA LinkGeneric 04/2006
1	AngiotensinsIBA 04/2006
1	Biomarkers (Surrogate Marker)IBA 02/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2006
1	Amyloidogenic ProteinsIBA 02/2006
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2006

Therapy/Procedure

12	Therapeutics 01/2022 - 04/2006
5	Secondary Prevention 01/2022 - 01/2007
3	Thrombolytic Therapy 01/2020 - 04/2006
2	Thrombectomy 10/2021 - 01/2020
1	Activities of Daily Living (ADL) 01/2012